Literature DB >> 9628599

Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure.

B H Bochner1, A J Figueroa, E C Skinner, G Lieskovsky, Z Petrovich, S D Boyd, D G Skinner.   

Abstract

PURPOSE: Salvage surgery followed by lower urinary tract reconstruction is a viable therapeutic option for patients in whom definitive radiation therapy for localized bladder or prostate cancer has failed. Improvements in surgical technique and postoperative care have significantly improved overall outcome. An enhanced understanding of the rhabdoid sphincteric mechanism responsible for maintaining urinary continence following cystoprostatectomy has helped make the orthotopic neobladder the procedure of choice for patients requiring lower urinary tract reconstruction. We describe our experience with salvage surgery and orthotopic bladder substitution following failed radical radiation therapy.
MATERIALS AND METHODS: We evaluated the complications of 18 patients in whom definitive radiation therapy (total minimum dose 60 Gy. or greater) for bladder or prostate cancer had failed. All patients underwent a salvage procedure with creation of an orthotopic neobladder.
RESULTS: Operative characteristics, postoperative outcomes and postoperative complications related or unrelated to urinary reconstruction were similar between irradiated and nonirradiated patients. Good day and night continence following surgery was reported by 67 and 56% of irradiated patients, respectively. Patients with poor postoperative continence were successfully treated with the placement of an artificial urinary sphincter.
CONCLUSIONS: Salvage surgery with orthotopic urinary reconstruction is a safe, effective procedure that provides a functional lower urinary tract in patients in whom definitive pelvic radiation therapy has failed.

Entities:  

Mesh:

Year:  1998        PMID: 9628599

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Current status of salvage robot-assisted laparoscopic prostatectomy for radiorecurrent prostate cancer.

Authors:  Bernardo Rocco; Gabriele Cozzi; Matteo Giulio Spinelli; Angelica Grasso; Daniela Varisco; Rafael F Coelho; Vipul R Patel
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

2.  Neobladder formation after pelvic irradiation.

Authors:  Richard E Hautmann; Robert de Petriconi; Bjoern G Volkmer
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

3.  Radical cystectomy is the treatment of choice for invasive bladder cancer.

Authors:  Faysal A Yafi; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

4.  Long term outcomes in the use of ileal ureter for radiation-induced ureteral strictures.

Authors:  M Francesca Monn; Joshua D Roth; Richard Bihrle; Matthew J Mellon
Journal:  Int Urol Nephrol       Date:  2018-06-15       Impact factor: 2.370

5.  Robotic Female Radical Cystectomy.

Authors:  Hong Truong; Victoria Maxon; Alvin C Goh
Journal:  J Endourol       Date:  2021-09       Impact factor: 2.619

6.  [Value of cystoprostatectomy in locally advanced prostate carcinoma].

Authors:  N Zantl; J E Gschwend
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

7.  Ileal conduit urinary diversion in patients with previous history of abdominal/pelvic irradiation.

Authors:  Sam S Chang; Gregory L Alberts; Joseph A Smith; Michael S Cookson
Journal:  World J Urol       Date:  2004-09-21       Impact factor: 4.226

8.  Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients.

Authors:  Bernard H Bochner; Nick Karanikolas; Richard R Barakat; Douglas Wong; Dennis S Chi
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

9.  [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].

Authors:  A Heidenreich; C Ohlmann; E Ozgür; U Engelmann
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

10.  Conservative treatment of invasive bladder cancer.

Authors:  N J Rene; F B Cury; L Souhami
Journal:  Curr Oncol       Date:  2009-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.